Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study

PURPOSE: Aromatase inhibitors (AI) have been shown to reduce breast cancer-related mortality in women with estrogen positive (ER+) breast cancer. The use of AIs, however, has been associated with higher rates of hypertension, hyperlipidemia, and cardiovascular (CV) events. METHODS: A cross-sectional...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Breast Cancer Res Treat
Prif Awduron: Blaes, Anne, Beckwith, Heather, Florea, Natalia, Hebbel, Robert, Solovey, Anna, Potter, David, Yee, Douglas, Vogel, Rachel, Luepker, Russell, Duprez, Daniel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6632072/
https://ncbi.nlm.nih.gov/pubmed/28801846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4447-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg